IRVINE, Calif., April 7, 2011 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX), a molecular diagnostics laboratory offering genetic array testing, a comprehensive profiling of chromosomes and ...

IRVINE, Calif., Nov. 3, 2010 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX) announced today that it will release its third quarter 2010 financial results on Wednesday, November 10, 2010.

At CombiMatrix Corp., a diagnostic laboratory in Irvine, white-cloaked techs sit hunched over microscopes while their gloved hands deftly pick through the remains of lost pregnancies, pulling the ...

CombiMatrix Corp (NASDAQ: CBMX), a molecular diagnostics company, announced on Thursday it has begun to explore strategic alternatives, including potential M&A activity and business development ...

It’s a little discussed fact that many pregnancies end in miscarriage – and it can be hard to understand why. CombiMatrix, an Orange County-based fetal diagnostic company, has developed a microarray ...

Investing.com - Shares of CombiMatrix Corp (NASDAQ:CBMX) rallied on Tuesday and were up about 40% on the home stretch to the closing bell with investors cheering a proposed merger of the company with ...

MUKILTEO, Wash., June 1, 2010 (GLOBE NEWSWIRE) -- CombiMatrix Corporation (Nasdaq:CBMX - News) announced today that it has instructed its investment bankers to cease work on identification and pursuit ...

Acacia Research Corporation has announced that its CombiMatrix has entered into a manufacturing-and-distribution agreement with Macrogen, Inc. The agreement establishes Macrogen as a key distributor ...

Irvine-based CombiMatrix Corp.’s shares jumped on Thursday after a report on the Seeking Alpha investor website suggested that its stock price will double by the end of the month. Shares of the ...

CombiMatrix Corporation (NASDAQ:CBMX) announced today that it has received a four year contract for $858,298 from NASA’s Ames Research Center to design and test a microfluidic system that incorporates ...

To significantly cut operating costs CEO to step down as part of restructuring Co to begin search for new CEO April 19 (Reuters) - Biotechnology firm CombiMatrix Corp said its chief executive officer ...

CombiMatrix has appointed a new CEO. Occupying that position will be Mark McDonough, currently the chief commercial officer of the firm. He replaces the retiring R. Judd Jessup, and will formally take ...